NovoCure Limited Accounts Payable for the year ending December 31, 2024: USD 105.09 M

NovoCure Limited Accounts Payable is USD 105.09 M for the year ending December 31, 2024, a 11.33% change year over year. Accounts payable are amounts owed by the company to suppliers or vendors for goods or services received but not yet paid.
  • NovoCure Limited Accounts Payable for the year ending December 31, 2023 was USD 94.39 M, a 10.79% change year over year.
  • NovoCure Limited Accounts Payable for the year ending December 31, 2022 was USD 85.20 M, a 17.35% change year over year.
  • NovoCure Limited Accounts Payable for the year ending December 31, 2021 was USD 72.60 M, a 35.33% change year over year.
  • NovoCure Limited Accounts Payable for the year ending December 31, 2020 was USD 53.65 M, a 45.29% change year over year.
Key Data
Date Accounts Payable Short-Term Debt Long-Term Debt Total Liabilities